1. Canada Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: other
Neptune Wellness Solutions Inc.

Neptune Wellness Solutions Inc.

OOTC:NEPTF
0.00
USD
0.00
(0.00%)
-18.85EPS
Nov 18Next Earn
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
TTM
Revenue per Share
444.93
573.43
558.63
590.58
16,134.39
9,049.33
12,353.22
15,258.22
12,891.48
12,986.22
14,303.16
17,709.18
9,629.99
12.38
Basic EPS, GAAP
-53.94
-58.18
-56.32
-381.72
-13,770.86
-16,790.02
-4,077.26
9,675.68
-12,232.01
-26,722.2
-49,765.66
-27,208.32
-11,065.71
-16.91
Free Cash Flow per Basic Share
-146.28
-179.88
-241.64
-481.96
-29,054.7
-24,459.12
-6,929.2
-6,974.95
-9,095.66
-20,066.42
-25,718.49
-20,583.67
-5,398.7
-5.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
278.54
397.27
785.74
1,271.02
1,026.84
820.97
708.39
1,190.43
904.32
1,427.33
975.2
433.21
-53.79
-9.13
Tangible Book Value per Share
235.93
355.74
747.32
1,236.64
988.65
797.6
527.58
1,024.55
715.53
753.06
540.63
38.64
-71.96
-10.24
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
Sales/Revenue/Turnover
12
17
19
25
18
12
17
21
18
21
35
61
71
52
Operating Margin (%)
-24.67
-9.17
-29.96
-59.63
-192.97
-273.6
-70.78
-81.5
-93.34
-234.55
-263.05
-141.31
-93.86
-118.77
Depreciation Expense
1
1
1
1
- -
1
2
3
2
6
19
8
4
2
Net Income, GAAP
-1
-2
-2
-16
-15
-22
-6
14
-17
-43
-123
-94
-82
-72
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-12.12
-10.15
-10.08
-64.64
-85.35
-185.54
-33.01
63.41
-94.88
-205.77
-347.93
-153.64
-114.91
-136.64
Working Capital
4
9
24
41
43
33
18
20
3
15
55
9
-24
-75
LT Debt
5
4
3
2
9
11
15
- -
- -
1
14
17
24
2
Total Equity
8
13
33
55
58
58
49
67
52
101
138
76
-37
-69
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
-18.55
-17.1
-9.7
-39.72
-29.93
-49.9
-13.18
25.51
-29.27
-56.12
-113.71
-106.8
- -
- -

Capital Structure

CAD

•

in mil. unless spec.
Jun'24
Sep'24
Dec'24
ST Debt
13
14
35
LT Borrowings
21
23
- -
LT Finance Leases
3
3
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1
2
5
Market Capitalization
4
4
- -

Working Capital

CAD

•

in mil. unless spec.
Jun'24
Sep'24
Dec'24
Total Current Assets
31
32
22
Cash, Cash Equivalents & STI
2
6
2
Accounts Receivable, Net
8
6
5
Inventories
18
16
13
Total Current Liabilities
60
68
97
Payables & Accruals
39
41
42
ST Debt
13
14
35
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.98%
-16.94%
-148.96%
Free Cash Flow
38.42%
49.32%
-43.8%
Net Income, GAAP
43.32%
13.88%
-12.85%
Sales/Revenue/Turnover
19.45%
31.61%
16.52%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
10
13
15
15
61
2023
21
17
17
16
71
2024
14
12
10
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-5,702.4
-3,722.9
-5,023.1
-303.64
-27,208.32
2023
-1,481.28
-209.01
252.95
-2.99
-11,065.71
2024
-1,087.58
-1.87
-5.49
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Michael A. de Geus
Full Time Employees
50
Sector
Health technology
Industry
Pharmaceuticals: other
Address
545 Promenade du Centropolis Laval QC Canada H7T 0A3
IPO Date
Jun 4, 2002
Website
neptunewellness.com
Similar Companies
Cipla Ltd (NSE:CIPLA)
Aurobindo Pharma Ltd (NSE:AUROPHARMA)
Lupin Limited (NSE:LUPIN)
Granules India Limited (NSE:GRANULES)
Revolution Medicines, Inc. (NASDAQ:RVMD)
Egyptian International Pharmaceutical Industries Co. (EGX:PHAR)
Business
Neptune Wellness Solutions Inc. operates as a consumer packaged goods company focused on health and wellness products, including nutraceuticals and organic baby food; its core offerings encompass omega-3 fish oils and nutritional supplements under brands such as Biodroga featuring MaxSimil absorption technology, vegan multi-omega gummies and soft gels under Forest Remedies, and organic baby food and toddler snacks under Sprout Organics; the company provides turnkey product development, extraction, and supply chain solutions leveraging expertise in marine oils, grain oils, and specialized ingredients. Neptune serves distributors, retail outlets, grocery stores, and e-commerce channels including forestremedies.com and sproutorganics.com, with operations spanning Canada, the United States, and international markets. Founded in 1998 and headquartered in Laval, Quebec, Canada, the company targets consumers seeking plant-based, sustainable lifestyle brands in the nutraceuticals and organic foods segments. Recent developments include the appointment of Michael De Geus as interim president and CEO following Michael Cammarata's resignation in February 2024, alongside Cedrick Billequey as interim COO; Neptune increased its ownership in Sprout Organics to approximately 89.5% in 2023 via debt-to-equity exchange and retains Stifel to explore strategic alternatives such as monetization, partnerships, or divestitures for the unit; earlier efforts encompassed a non-binding letter of intent in 2023 to acquire Datasys Group for data-marketing and AI capabilities, a strategic review launched in 2023 aiming for pure-play CPG focus by 2024, and Nasdaq delisting proceedings.